Kora Dębu (Quercus Cortex)

Quercus Cortex is rich in tannins that create a protective protein layer on mucosal surfaces, reducing secretions and providing an astringent effect. The flavonoids and other polyphenols modulate inflammatory pathways by inhibiting prostaglandin synthesis, which helps lessen irritation and swelling in skin and mucous membranes.

The appropriate dose of Kora Dębu is determined by the prescribing healthcare professional based on the individual’s condition, age, and overall health status. Patients should follow the specific instructions provided by their clinician and not adjust the dosage without medical guidance.

Safety data for Quercus Cortex during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Kora Dębu to weigh potential benefits against any unknown risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with other astringent herbs such as witch hazel or tannic acid extracts, Quercus Cortex offers a similar protein‑precipitating action but also contains a broader spectrum of flavonoids that may provide additional anti‑inflammatory benefits. Choice of product often depends on formulation, concentration, and individual tolerance.

Kora Dębu should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keeping the product sealed helps maintain its stability and potency throughout its shelf life.

Kora Dębu can be administered orally as a tincture or lozenge, applied topically to the skin, or used as an oromucosal rinse, depending on the formulation supplied. The route of administration is chosen by the prescriber to match the therapeutic target, such as skin irritation or oral ulceration.

The most serious risks include rare severe allergic reactions such as anaphylaxis, potential liver enzyme elevation (hepatotoxicity), and rare cases of renal impairment. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, jaundice, or sudden swelling.

Individuals with a known hypersensitivity to oak bark or related plant species should avoid Kora Dębu. Additionally, patients taking anticoagulant therapy, high‑dose iron supplements, or those with severe liver or kidney disease should consult a healthcare professional before use.